Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kymera Therapeutics, Inc.

23.69
-2.6700-10.13%
Post-market: 23.690.00000.00%18:21 EDT
Volume:709.39K
Turnover:17.14M
Market Cap:1.54B
PE:-7.94
High:25.07
Open:24.64
Low:23.64
Close:26.36
Loading ...
Aug 20, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Jul 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2024

Major Issues Report

Form 8-K - Current report
Apr 01, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership